What the future holds.
PSID owns near 30 U.S. and International patents on their technology. This isn't an opinion, it's a fact.
PSID has FDA approval on its diabetes technology which allows the company to sell its diabetes products to the public. Again, not an opinion, a fact.
PSID is one of two companies after the $5.7 billion dollar DHS BIoWatch contract. Someone earlier said the DHS contract provides that a "small company" to get 40% of the contract. I believe that statement is not true and here is why: PSID's BioWatch system is the ONLY system that performed "as advertised" in field test after field test with the DHS. Grummans on the other hand, did not. DHS is not going to award 60% of a $5.7 billion dollar contract to a company ( Grumman) whos product does not work. Personally, I believe, based on the previous, that PSID will partner with Boeing OR Grumman for the entire contract. I would not be surprised to see Grumman offer to buy the technology from PSID either. PSID is the only working system in this contract bidding. PSID will get the contract. This is a no brainer.
PSID's diabetes area is where I see the big money to lie. With a global market of $380 billion a year, PSID's IGlucose and EasyCheck devices are the new standard.
Next 60 days will be very interesting, very interesting indeed.
Market Data 
Markets 
AI
